Observed Signal · Oct 7, 2026 · Funding · Source: EU-Startups (European Venture) · Impact: 1/5 · Sentiment: Positive
Cori Clinical Raises €3.8M to Accelerate Clinical Trials
London-based Cori Clinical, a startup providing an AI-powered intelligence layer for clinical trials, has raised €3.8 million in a Seed round led by Breega, with participation from Enzo, Heartfelt, Together Ventures, and Bynd. The company plans to use the funds to expand delivery capacity, grow its team, and deepen regulatory and clinical intelligence in its platform. Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health. Founded in 2025 by Jorn Jansen Schoonhoven (CEO) and Patricio Fernández (CTO), Cori Clinical creates a 'living blueprint' for trials, integrating internal knowledge with external data from registries and regulatory bodies like FDA, MHRA, and EMA. The startup claims its approach could reduce average trial set-up costs by at least 33%. It already works with two of the top five global CROs and has customers like Erasmus MC.
The funding in clinical trial technology is not directly related to AdTech, MarTech, or AI for advertising. It is a health-tech startup, which falls outside the industry relevance criteria.
Track Breega Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Cori Clinical raised €3.8 million in a Seed round led by Breega.
- Participants include Enzo, Heartfelt, Together Ventures, and Bynd.
- Dr. Emma Ogburn joins as Chief Clinical Officer from Lindus Health.
- Cori Clinical claims its approach could reduce trial set-up costs by at least 33%.
- The company works with two of the top five global CROs and customers like Erasmus MC.
Connected Companies & Entities
2 Entities mapped“led the funding round...”
“participation in the funding round...”
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
DeepIntent launches agentic ad platform Cora for pharma marketing
DeepIntent, a healthcare-focused adtech firm, has launched Cora, an AI-powered agentic advertising platform designed for pharmaceutical marketers. The platform uses multiple AI agents to handle campaign planning, audience strategy, and media execution, including linear TV via a VideoAmp integration. Cora aims to speed up marketing workflows, with beta tests showing a 50% reduction in planning cycles and over 95% of clients reporting faster processes. This launch follows DeepIntent's majority stake sale to Vitruvian Partners, which provided $637 million to develop AI tools. The company targets the growing complexity of pharma marketing, especially for niche drugs targeting small patient populations. Cora is also powered by Helix, a data application providing aggregated healthcare data, including payer signals and drug coverage insights.
Corridor Raises $25M Seed for AI Health Benefits Brokerage
Corridor, an AI-powered health benefits brokerage for small businesses, announced a $25 million seed round led by Bain Capital Ventures. The startup combines human advisors with AI agents that handle administrative tasks like checking in-network doctors, scheduling care, and updating insurance info. Founded by Jackson Wagner (ex-Scale AI) and Eric Qian, with CEO Nikhil Aggarwal, the company aims to address the underserved SMB market. Investors include BoxGroup and executives from OpenAI, Scale AI, and Ramp. Corridor is preparing for Q4, when most small businesses choose their health plans.
Calliora raises $6M for AI hospital billing accuracy
Munich-based startup calliora has raised $6 million (approx. €5.1 million) in a pre-seed round led by Bertelsmann Healthcare Investments (BHI) and Swiss VC redalpine. The company's AI platform helps hospitals find billing errors before invoices are sent to health insurers. This comes as German hospitals face stricter audit quotas from 2027 under the GKV contribution rate stabilization law, where high error rates could lead to 100% of invoices being audited. The platform integrates with existing hospital systems, covering coding, case review, MD audit management, and controlling. According to calliora, the platform is already in regular operation in hospitals across five German states, reducing per-case workload by over half and closing more than 90% of identified gaps before billing. The funds will be used to grow the AI, engineering, and product teams. The startup was founded in 2023 by Frederik Träuble and Jonas Wildberger.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.